A new observer independent method to assess therapy response in children with severe asthma based on daily lung function

N. van Sprang, E. Delgado-Eckert, C. Häcki, A. Bosschaart, U. Frey, A. Boehmer (Rotterdam, Netherlands; Basel, Davos, Switzerland)

Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Session: Uncontrolled and severe asthma in children
Session type: Thematic Poster Session
Number: 1137
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. van Sprang, E. Delgado-Eckert, C. Häcki, A. Bosschaart, U. Frey, A. Boehmer (Rotterdam, Netherlands; Basel, Davos, Switzerland). A new observer independent method to assess therapy response in children with severe asthma based on daily lung function. Eur Respir J 2013; 42: Suppl. 57, 1137

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Xavier Quantin (Montpellier, France) - 09.09.2013 11:15
Hello, this is a very interresting abstract. How many patients were included and what was the retention rate? X Quantin France Montpellier
You must Login to comment this presentation.


Related content which might interest you:
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Is it possible to identify phenotypes of problematic severe asthma in children using fluctuation based clustering?
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016

Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014


Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013


Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016

Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013



4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Quantitative analysis of severe asthma exacerbation requiring continuous inhalation therapy by measurements of modified pulmonary index score
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013


A scoring algorithm for predicting the presence of adult asthma
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015


The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015


Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


TH2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013

Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013